In Vivo Expression of MHC Class I Genes Depends on the Presence of a Downstream Barrier Element

Regulation of MHC class I gene expression is critical to achieve proper immune surveillance. In this work, we identify elements downstream of the MHC class I promoter that are necessary for appropriate in vivo regulation: a novel barrier element that protects the MHC class I gene from silencing and elements within the first two introns that contribute to tissue specific transcription. The barrier element is located in intergenic sequences 3′ to the polyA addition site. It is necessary for stable expression in vivo, but has no effect in transient transfection assays. Accordingly, in both transgenic mice and stably transfected cell lines, truncation of the barrier resulted in transcriptional gene silencing, increased nucleosomal density and decreased histone H3K9/K14 acetylation and H3K4 di-methylation across the gene. Significantly, distinct sequences within the barrier element govern anti-silencing and chromatin modifications. Thus, this novel barrier element functions to maintain transcriptionally permissive chromatin organization and prevent transcriptional silencing of the MHC class I gene, ensuring it is poised to respond to immune signaling.

[1]  D. Bodine,et al.  An insulator with barrier-element activity promotes alpha-spectrin gene expression in erythroid cells. , 2009, Blood.

[2]  D. Singer,et al.  Histone Modifications, but Not Nucleosomal Positioning, Correlate with Major Histocompatibility Complex Class I Promoter Activity in Different Tissues In Vivo , 2008, Molecular and Cellular Biology.

[3]  H. Willard,et al.  An RNA Polymerase III-Dependent Heterochromatin Barrier at Fission Yeast Centromere 1 , 2007, PloS one.

[4]  A. Tong,et al.  Genome-wide, as opposed to local, antisilencing is mediated redundantly by the euchromatic factors Set1 and H2A.Z , 2007, Proceedings of the National Academy of Sciences.

[5]  G. Felsenfeld,et al.  USF1 Recruits Histone Modification Complexes and Is Critical for Maintenance of a Chromatin Barrier , 2007, Molecular and Cellular Biology.

[6]  Dustin E. Schones,et al.  High-Resolution Profiling of Histone Methylations in the Human Genome , 2007, Cell.

[7]  T. Shimojima,et al.  Drosophila GAGA factor directs histone H3.3 replacement that prevents the heterochromatin spreading. , 2007, Genes & development.

[8]  Hui Li,et al.  HPV16E7 mediates HADC chromatin repression and downregulation of MHC class I genes in HPV16 tumorigenic cells through interaction with an MHC class I promoter. , 2006, Biochemical and biophysical research communications.

[9]  James R Broach,et al.  Single-cell observations reveal intermediate transcriptional silencing states. , 2006, Molecular cell.

[10]  P. Majumder,et al.  The Human Major Histocompatibility Complex Class II HLA-DRB1 and HLA-DQA1 Genes Are Separated by a CTCF-binding Enhancer-blocking Element* , 2006, Journal of Biological Chemistry.

[11]  C Giuliani,et al.  Transcriptional regulation of major histocompatibility complex class I gene by insulin and IGF-I in FRTL-5 thyroid cells. , 2006, The Journal of endocrinology.

[12]  J. E. Halley,et al.  Telomeric heterochromatin boundaries require NuA4-dependent acetylation of histone variant H2A.Z in Saccharomyces cerevisiae. , 2006, Genes & development.

[13]  S. Schreiber,et al.  Histone Variant H2A.Z Marks the 5′ Ends of Both Active and Inactive Genes in Euchromatin , 2005, Cell.

[14]  C. Bonifer,et al.  The replacement histone H2A.Z in a hyperacetylated form is a feature of active genes in the chicken , 2005, Nucleic acids research.

[15]  R. Kamakaka,et al.  Barrier function at HMR. , 2005, Molecular cell.

[16]  Kevin Struhl,et al.  Heterochromatin formation involves changes in histone modifications over multiple cell generations , 2005, The EMBO journal.

[17]  Martha R. Stampfer,et al.  Chromatin Inactivation Precedes De Novo DNA Methylation during the Progressive Epigenetic Silencing of the RASSF1A Promoter , 2005, Molecular and Cellular Biology.

[18]  D. Singer,et al.  MHC class I expression regulates susceptibility to spontaneous autoimmune disease in (NZBxNZW)F1 mice , 2005, Lupus.

[19]  A. West,et al.  Recruitment of histone modifications by USF proteins at a vertebrate barrier element. , 2004, Molecular cell.

[20]  D. Butcher,et al.  DNA binding sites for putative methylation boundaries in the unmethylated region of the BRCA1 promoter , 2004, International journal of cancer.

[21]  L. Pillus,et al.  Molecular Requirements for Gene Expression Mediated by Targeted Histone Acetyltransferases , 2004, Molecular and Cellular Biology.

[22]  G. Felsenfeld,et al.  The 5'-HS4 chicken beta-globin insulator is a CTCF-dependent nuclear matrix-associated element. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Matsuoka,et al.  Sea urchin insulator protects lentiviral vector from silencing by maintaining active chromatin structure , 2004, Gene Therapy.

[24]  Xin Bi,et al.  Formation of Boundaries of Transcriptionally Silent Chromatin by Nucleosome-Excluding Structures , 2004, Molecular and Cellular Biology.

[25]  T. Chiba,et al.  Barrier Proteins Remodel and Modify Chromatin To Restrict Silenced Domains , 2004, Molecular and Cellular Biology.

[26]  H. Kuipers,et al.  Transcriptional regulation of antigen presentation. , 2004, Current opinion in immunology.

[27]  G. Felsenfeld,et al.  Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9 , 2004, The EMBO journal.

[28]  E. Rubio,et al.  Thec-myc Insulator Element and Matrix Attachment Regions Definethe c-myc ChromosomalDomain , 2003, Molecular and Cellular Biology.

[29]  B. Garmy-Susini,et al.  Down‐Regulation of HLA‐G1 Cell Surface Expression in Human Cytomegalovirus Infected Cells , 2003, American journal of reproductive immunology.

[30]  S. Ferrone,et al.  Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[31]  B. Turner,et al.  Immunoprecipitation of native chromatin: NChIP. , 2003, Methods.

[32]  D. Singer,et al.  Distinct Transcriptional Pathways Regulate Basal and Activated Major Histocompatibility Complex Class I Expression , 2003, Molecular and Cellular Biology.

[33]  Hiten D. Madhani,et al.  Conserved Histone Variant H2A.Z Protects Euchromatin from the Ectopic Spread of Silent Heterochromatin , 2003, Cell.

[34]  Michael Litt,et al.  The insulation of genes from external enhancers and silencing chromatin , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Félix Recillas-Targa,et al.  Position-effect protection and enhancer blocking by the chicken β-globin insulator are separable activities , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[36]  G. Yang,et al.  DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas. , 2001, Carcinogenesis.

[37]  R. Kamakaka,et al.  RNA polymerase III and RNA polymerase II promoter complexes are heterochromatin barriers in Saccharomyces cerevisiae , 2001, The EMBO journal.

[38]  R. Ricciardi,et al.  Association of histone deacetylase with COUP-TF in tumorigenic Ad12-transformed cells and its potential role in shut-off of MHC class I transcription. , 2000, Virology.

[39]  S. Smerdon,et al.  Human HMG box transcription factor HBP1: a role in hCD2 LCR function , 1999, The EMBO journal.

[40]  D. Singer,et al.  Upstream Stimulatory Factor Regulates Major Histocompatibility Complex Class I Gene Expression: the U2ΔE4 Splice Variant Abrogates E-Box Activity , 1999, Molecular and Cellular Biology.

[41]  G. Felsenfeld,et al.  Loss of transcriptional activity of a transgene is accompanied by DNA methylation and histone deacetylation and is prevented by insulators. , 1998, Genes & development.

[42]  D. Littman,et al.  Regulation of IL-4 expression by activation of individual alleles. , 1998, Immunity.

[43]  D. Kioussis,et al.  Locus control regions: overcoming heterochromatin-induced gene inactivation in mammals. , 1997, Current opinion in genetics & development.

[44]  D. Singer,et al.  Active Repression of Major Histocompatibility Complex Class I Genes in a Human Neuroblastoma Cell Line* , 1996, The Journal of Biological Chemistry.

[45]  D. Kioussis,et al.  Locus Control Region Function and Heterochromatin-Induced Position Effect Variegation , 1996, Science.

[46]  F. Kashanchi,et al.  HIV Tat represses transcription through Sp1-like elements in the basal promoter. , 1995, Immunity.

[47]  M. Saji,et al.  Hormonal modulation of major histocompatibility complex class I gene expression involves an enhancer A-binding complex consisting of Fra-2 and the p50 subunit of NF-kappa B , 1995, The Journal of Biological Chemistry.

[48]  M. Kalos,et al.  Position-independent transgene expression mediated by boundary elements from the apolipoprotein B chromatin domain , 1995, Molecular and cellular biology.

[49]  T. Howcroft,et al.  MHC class I gene expression is negatively regulated by the proto‐oncogene, c‐jun. , 1993, The EMBO journal.

[50]  D. Singer,et al.  Resistance of MHC class I-deficient mice to experimental systemic lupus erythematosus. , 1993, Science.

[51]  D. Singer,et al.  Repression of MHC class I gene promoter activity by two-exon Tat of HIV. , 1993, Science.

[52]  L. Harrison,et al.  Nonimmune thyroid destruction results from transgenic overexpression of an allogeneic major histocompatibility complex class I protein , 1993, Molecular and cellular biology.

[53]  D. Singer,et al.  In vivo function of regulatory DNA sequence elements of a major histocompatibility complex class I gene , 1992, Molecular and cellular biology.

[54]  L. Harrison,et al.  Overexpression of class I major histocompatibility complex accompanies insulitis in the non-obese diabetic mouse and is prevented by anti-interferon-γ antibody , 1991, Diabetologia.

[55]  K. Mikoshiba,et al.  Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes , 1991, Nature.

[56]  S. Weissman,et al.  Identification of cis sequences controlling efficient position-independent tissue-specific expression of human major histocompatibility complex class I genes in transgenic mice , 1991, Molecular and cellular biology.

[57]  D. Singer,et al.  Expression of a class I MHC transgene: regulation by a tissue-specific negative regulatory DNA sequence element. , 1990, The New biologist.

[58]  V. Corces,et al.  The Drosophila melanogaster suppressor of Hairy-wing protein binds to specific sequences of the gypsy retrotransposon. , 1988, Genes & development.

[59]  G. Morahan,et al.  Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic β cells , 1988, Nature.

[60]  D. Singer,et al.  Identification of negative and positive regulatory elements associated with a class I major histocompatibility complex gene , 1988, Molecular and cellular biology.

[61]  M. Capecchi,et al.  Expression of a microinjected porcine class I major histocompatibility complex gene in transgenic mice. , 1985, Science.

[62]  D. Singer,et al.  Expression of a class I MHC transgene: effects of in vivo α/β-interferon treatment , 2006, Immunogenetics.

[63]  R. Rezzani,et al.  HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[64]  A. Stasiak-Barmuta,et al.  Monocytes in children with leukemias and lymphomas -- down-regulation of HLA and costimulatory molecules. , 2004, Acta biochimica Polonica.

[65]  D. Singer,et al.  Expression of nonclassical MHC class Ib genes , 2003, Immunologic research.

[66]  R. Ehrlich,et al.  Expression of a class I MHC transgene: effects of in vivo alpha/beta-interferon treatment. , 1989, Immunogenetics.